CURRICULUM VITAE



Curriculum Vitae

Name : PRASAD NARAYANAN

Date of Birth : 30th September 1975

Present Address : Dr.Prasad Narayanan

Consultant Medical Oncologist at Mazumdar Shaw Cancer Center and Narayana Hrudayalaya Multispecialty Hosptial

No 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore 560099

Phone Off: 91-80-27835000 to 18

Mobile-09902599881

Fax: 91-80-27832648

Email: prasadnarayanan@

prasad@

Permanent Address : C/o Mr. A Narayanan

TD Nagar 55

Anantavilas

TDRoad

Kollam, Kerala - 691013

Telephone: (+91)-474- 2793563

Mobile - 09446525866

Alternate address : B 004, Block B, Daddy Garden, Kammasandra, Hebbagudi, Electronic City post, 560100

Email: prasadoncology@

prasadnarayanan@

EDUCATIONAL QUALIFICATIONS:

|Institutions |Year |Certificate |

|Catalyst Clinical Services | 2008 |Professional Diploma in Clinical Research|

|European Society of Medical Oncology | 2007 |ESMO certification in Medical oncology |

|Tata Memorial hospital, Mumbai | 2003-2007 | D.M. (Med Oncology) |

|NSCB Medical College, Jabalpur, Madhya Pradesh |2000-2003 |M.D. (Gen MD) |

|Govt. Medical College, Trivandrum | 1993-1998 |M.B.B.S |

Licensure : Medical Council of India (Kerala)

Registration No. 27995

Maharashtra Medical Council

Registration No 2004/01/219

MEMBER : ESMO (European Society of Medical Oncology)

: ICON (Indian Cooperative Oncology Network)

PRESENT APPOINTMENT

Consultant Medical Oncologist at Mazumdar Shaw Cancer Center and Narayana Hrudayalaya Multispecialty Hosptial (The cancer Institute is one of the largest cancer centers in the world with state of art medical, radiation and surgical oncology departments with site specific focused cancer care)

Clinical Training and professional experience

1. Assistant Professor in Medical Oncology at Amrita Institute of Medical Sciences, Cochin from March 2007 to May 2009.

2. Specialist Registrar in the department of Medical Oncology at Tata Memorial Centre.Mumbai from October 2006- February 2007.

3. Senior resident in the department of Medical Oncology, Tata Memorial Hospital, Mumbai. Carried out autologous and allogenic BMT as part of training (2003-2006).

4. Junior resident in the department of Internal Medicine, NSCB Medical College, Jabalpur, Madhya Pradesh (2000-2003).

5. One year compulsory rotating internship at Trivandrum Medical College, Trivandrum, Kerala, including 3 months at an attached community hospital. Rotation in various clinical departments at Trivandrum Medical College (1998-1999)

Teaching Experience

1. DNB trainees/ medical students/ nursing students in the department of medical oncology at Amrita institute of medical sciences, Cochin (2007 - 2009).

2. Junior residents and oncology nursing students as Senior Resident, Medical Oncology, Tata Memorial Hospital, Mumbai (20003-2007).

3. Medical students as Junior Resident, Internal Medicine, NSCB Medical College, Jabalpur, Madhya Pradesh (2000-2003).

Major Interests

1. Clinical research

2. Stem cell transplantation

3. Head and neck and breast cancer

4. Paediatric Oncology

OTHER ACADEMIC ACTIVITIES/ ACHIEVEMENTS

1. Contributed as Author in chapter titled “ Role of chemotherapy in the management of Head and Neck squamous cell cancer in AHEAD education book 2008.

2. Contributed as Author in chapter titled “Treatment of Non Small Cell Lung” In ‘The Oncology Knowledge Bank’ Vol 2, 2008.

3. Contributed as Author in chapter titled “Treatment of Lung Cancer in the Elderly” In ‘The Oncology Knowledge Bank’ Vol 1, 2006.

4. Won first prize for the Best Thesis competition in ICON conference held in Trivandrum September 2006.

5. Submitted a Project Titled “CD 26 expression and its correlation with engraftment In hematopoietic stem cell transplant” for ACORD workshop in Queensland Australia in September 2006. Got an International Travel Grant and Scholarship to attend the same.

6. Second Prize in Debate Competition in 14th ICON Conference held in April 2006.

7. Participated as a Delegate during the Workshop on Preparing Cochrane Reviews held at Tata Memorial Hospital, Mumbai in March 2005.

8. First Prize in Quiz Competition in Mumbai Hematology Group annual meeting 2005 held in TMH Mumbai.

9. Completed the Cardiopulmonary Resuscitation Provider Course Conducted by the Department of Anaesthesia, Tata Memorial Centre in March 2004.

10. Conducted Quiz Competition in Mumbai Hematology Group annual meeting 2004 held in SION hospital Mumbai.

11. Second Prize in Quiz Competition in MPICON 2002.

conferences ATTENDED

1. Faculty moderator for panel discussion in FHNO 2009 at Kochi in October 2009.

2. Faculty for ICON 2009 in Mumbai September 2009.

3. Faculty for ISMPO Best Of ASCO Symposium in Bangalore August 2009.

4. Organised the CME in Heamato oncology at Narayana Hrudayalaya August 2009.

5. Faculty lecture on Chemotherapy at Rajiv Gandhi Health University Bangalore July 2009.

6. Delivered lecture in Asia Pacific Lung Cancer Conference in Hyderabad in December 2008.

7. “From Clinical Research to publication” by John Hopkins University at Singapore in August 2008.

8. First Asia Pacific EGFR Advisor’s Network (EAN) meeting in July 2008 at Hongkong.

9. Faculty in ICON conference in Bhubaneshwar in March 2008.

10. Delivered lecture in AHEAD 2008 meeting in AIMS Kochi in Feb 2008.

11. Attended as Faculty at ISMPO meeting in Bhutan on Febrile Neutropenia.

12. SIOP (International Society of Pediatric Oncology) conference in Mumbai 2007.

13. Evidence Based Meeting in Tata Memorial Centre in February 2007.

14. Participated in International Update of Hematology January 2007.

15. ICON conference in Trivandrum September 2006.

16. Participated in ACORD Australia in August 2006.

17. ICON conference in Dehradun April 2006.

18. Participated in the International Update on Multiple Myeloma held at Bombay Hospital in January 2006.

19. Participated as speaker in Chemotherapy Workshop at Tata Memorial Centre in December 2005.

20. International Update in Haematology at Bombay Hospital in September2005.

21. APICON 2005 in Mumbai.

22. ASCO 2005 May 13-17 in Orlando, Florida.

23. 3rd conference of Federation of Oncologists of SAARC Countries in April 2005.

24. XI th National CME in haematology in Bombay Hospital in April 2005.

25. EBM 2005 in Tata Memorial Centre in February 2005.

26. International Update on Hematological Malignancies in Mumbai on January 2005.

27. ASH-2004 update in Mumbai on 30th January 2005.

28. International Conference on Human Genome Update in Hyderabad in August 2004.

29. 28th Annual Conference of Mumbai Hematology Group in Mumbai, in March 2004.

30. ASH-2003 update in Mumbai on 1st February 2004.

31. Evidence Based Meeting at Tata Memorial Hospital, Mumbai, in February 2004.

32. Attended Evidence Based Meeting at Tata Memorial Hospital, Mumbai, in Feb 2003.

33. Attended MPICON, Madhya Pradesh 2002.

Research Experience

1. Submitted the MD thesis titled "Microalbuminuria in NonDiabetic Myocardial Infarction" under Prof M.K. Parashar (MD Thesis 200-2003).

2. Participated in a clinical trial ' An evaluation of safety and efficacy of G-CSF in prevention of neutropenia in patients receiving cancer chemotherapy '. Protocol IPL-IBT-P1-02 (2004).

3. Participated in A Phase III randomized, open label study of IV edotecarin vs temozolamide or carmustine or lomustine in patients with glioblastoma multiforme. Edoagl-8725-001 (2004).

4. Participated in a double blind, placebo controlled, parallel, multicentre, randomized, phase III survival study comparing Iressa to Best supportive care in advanced NSCLC. 18391L/0709 (2004).

5. Submitted the DM thesis titled “Advanced NSCLC (Stage IIIB and Stage IV). Efficacy and safety evaluation of Low Dose Prolonged Infusion Gemcitabine and standard carboplatin doublet” under Dr Prof P.M.Parikh. (DM Thesis 2003-2006).

STEM TRANSPLANT RELATED ACTIVITIES

Was actively involved in stem cell transplant related activities in TMH. Have done atleast 50 stem cell transplants including Auto, Allo, Haplo and cord blood transplant. Also published/presented stem cell transplant related activities in National and International venues.

1. Role of Itraconazole for prophylaxis of fungal infections in BMT setting [1032P]. Bakshi A, Goyal L, Hingmire S, Mandhaniya S, Prasad N, Bajpai J, Bhagwat R, Mishra BK, Sastry PSRK, Parikh PM. 31st ESMO Congress, Istanbul, Turkey, September 29-October 3, 2006.

2. Prasad N, R Bhagwat, PSRK Sastry, H Gadade, G Biswas, A Khadwal,A Bakshi,PMParikh :Autologous Stem Cell Transplantation in MM-A Single Institution experience :3rd Conference of Federation of Oncologists of SAARC countries.

3. Prasad. N, Sastry PSRK, B.K.Mishra, Sushil M, Roshni Bhagwat, Ashish Bakshi, G Biswas, P.M.Parikh. Outcome of Allogenic Stem Cell Transplant in CML analyzed according to the EBMT Score based risk groups – A Single Institution Experience. Biology of Blood and Marrow Transplantation.

4. A Khadwal, Prasad N, G Biswas, R Bhagwat, A Bakshi, PSRK Sastry, P M Parikh ABO incompatibility in allogenic SCT. Proceedings of 10th conference of APBMT.Oct 13-16,2005 China

5. PSRK Sastry, R Bhagwat, G Biswas, A Khadwal, Prasad N, A Bakshi, PM Parikh. Trial of amifostine in autologous stem cell transplant. Bone Marrow Transplant. 2005 Nov 7.

6. R Bhagwat, A Khadwal, G Biswas, Prasad N, P Kulkarni, PSRK Sastry, A Bakshi, PM Parikh, Late Infectious complications after hematopoietic stem cell transplantation. Proceedings of 10th conference of APBMT.Oct 13-16, 2005 China.

7. G Biswas, PSRK Sastry, Prasad N A Khadwal, R Bhagwat, A Bakshi, S Basu, N Nair, PM Parikh. Response Evaluation with FDG-PET pre and post ASCT in lymphoma. Proceedings of 10th conference of APBMT.Oct 13-16, 2005 China.

8. Submitted a Project Titled “CD 26 expression and its correlation with engraftment In hematopoietic stem cell transplant”. This was developed in ACORD workshop in Queensland, Australia and has been cleared by TMH scientific and ethics committee.

CLINICAL TRIALS

Has been a part of multiple Phase I, II, III, IV trials at Amrita Institute of Medical Sciences as Principal Investigator and Co – Investigator.

1. Principal Investigator: NU 07B1: A Double-Blind, Randomized Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo when Administered in Combination with Paclitaxel in Patients with Locally Recurrent or Metastatic Breast Cancer.

2. Principal Investigator: L00070 IN 305 B0: A phase III trial of vinflunine + capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistant

3. Co- Investigator: H3E-MC-JMHR: A Randomized Phase 3 Study of Pemetrexed in Combination with Cisplatin Versus Cisplatin Monotherapy in patients with Recurrent or Metastatic Head and Neck Cancer.

4. Co- Investigator: FM-CL1: A Phase I/IIa, Open-Label, Dose-Escalation Study to Determine the Safety, Tolerance, and Preliminary Activity of Intravenous High-Dose Fluphenazine HCl in Patients with Advanced Multiple Myeloma.

5. Co- Investigator: EGF102988: Randomized phase III study of adjuvant postoperative lapatinib with concurrent chemotherapy and radiation therapy in patients with SCCHN.

6. Co- Investigator: EGF110656: A Phase III Study of Erbb2 Positive Advanced or Metastatic Gastric or Esophageal or Gastroesophageal Junction Adenocarcinoma Treated With Capecitabine Plus Oxaliplatin With Or Without Lapatinib.

7. Co- Investigator: EFC6521: A multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of AVE5026 in the Prevention of Venous Thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy.

8. Co- Investigator: A4061032: AXITINIB (AG-013736) as Second Line Therapy for Metastatic Renal Cell Cancer: AXIS TRIAL.

9. Co- Investigator: FM-CL2: Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine HCl Monotherapy in Relapsed or Relapsed-and-Refractory Multiple Myeloma.

LECTURES & ORAL PRESENTATIONS

1. Delivered a lecture on ‘Systemic treatment of head and neck cancer ‘ at St Johns Medical College on 22 Feb 2010.

2. Delivered a Lecture on ‘Basics of Cancer Chemotherapy’ at Pan Africans e – network on 02 December 2009.

3. Moderated a panel discussion on role of chemotherapy in Head and Neck Cancer at IMA Hall Kochi as a part of FHNO 2009 in October 2009.

4. Moderated the session on best project proposal at 21st ICON meeting from 18th to 20th September 2009 at Mumbai.

5. Delivered an invited lecture titled ‘ Induction chemotherapy in Head and Neck Cancer – present role and future directions’ at 21st ICON meeting from 18th to 20th September 2009 at Mumbai.

6. Participated at ISMPOs Best of ASCO meeting on 8th and 9th August 2009 as faculty and chaired the session on Non Small Cell Lung Cancer at Bangalore.

7. Organised the 2nd CME in Hemato – Oncolgoy with focus on Myeloma and lymphoma at Narayana Health City on 1st August 2009

8. Delivered an invited lecture titled ‘ Recent advances in cancer chemotherapy and implications to future’ at Symposium on Cancer Care at Rajiv Gandhi University of Health Sciences, Karnataka on 24/07/09.

9. Faculty lecture on ‘combining chemotherapy and targeted therapy in NSCLC – Lung Cancer Update Mumbai June 2009.

10. Faculty lecture on Prognostic and Predictive markers in NSCLC at Asia Pacific Lung Cancer Conference in Hyderabad in December 2008.

11. Faculty lecture on “Adjuvant chemotherapy in stomach cancer “ at ICON 2008 in March 2008.

12. Faculty lecture “ Role of chemotherapy in head and neck cancer” at AHEAD 2008 meeting in AIMS Kochi.

13. Faculty Panel discussion “ Neuroendocrine tumors of Pancreas” at AGOICON 2008 at Kochi.

14. Faculty lecture on ‘ G - CSF guidelines in Febrile neutropenia ‘ at ISMPO conference in Bhutan in November 2007.

15. Vora T, Arora B, Goyal L, Prasad N, Padhye B, Mishra BK, Banavali S, Bhagwat R, Kelkar R, Biswas S, Kurkure P, Parikh PM Clinico-bacteriologic profile of emerging super bugs in pediatric oncology patients: experience from a tertiary care center in a developing country Submitted for SIOP 2006 meeting.

16. Lecture on ‘Recent advances in Cancer Chemotherapy’ in the Chemotherapy Workshop held in TMH on 2nd December 2005.

17. G Biswas, PSRK Sastry, N Prasad, A Khadwal,R Bhagwat, A Bakshi,S Basu,N Nair, PM Parikh. Response Evaluation with FDG-PET pre and post ASCT in lymphoma. Proceedings of 10th conference of APBMT.Oct 13-16,2005 China.

18. R Bhagwat,A Khadwal,G Biswas, N Prasad, P Kulkarni,PSRK Sastry, A Bakshi,PM Parikh , Late Infectious complications after hematopoietic stem cell transplantation . Proceedings of 10th conference of APBMT.Oct 13-16,2005 China.

19. G Biswas, N Karanth, N Prasad, R Bhagwat, A Bakshi, D Maru, S Gujral, S Gupta, R Nair, PM Parikh: Profile of Primary Thyroid NHL: 10 years experience: 3rd Conference of Federation of Oncologists of SAARC countries.

20. N Prasad, R Bhagwat, PSRK Sastry, H Gadade, G Biswas, A Khadwal, A Bakshi, PMParikh: Autologous Stem Cell Transplantation in MM-A Single Institution experience: 3rd Conference of Federation of Oncologists of SAARC countries.

21. G Biswas, PM Parikh, R Nair, R Bhagwat, A Bakshi, Prasad N, VR Pai, S Gupta: Rituximab in lymphoproliferative malignancies: Single institutional experience. Mumbai Hematology Group Annual meeting March 2005(Dr JC Patel Award session).

22. Khadwal, Prasad N, A V Bakshi, R Bhagwat, Sastry PSRK, Parikh PM: ABO incompatibility between donor and recipient in allogenic stem cell transplantation: Does it impact outcome? A TMH experience. Mumbai Hematology Group Annual meeting March 2005.

23. Prasad N, Goyal L, Biswas G, Bhagwat R, Kulkarni P, Nair R, Gupta S, Pai VR, Parikh P. Rituximab in Non-Hodgkins Lymphoma - Tata Memorial Hospital experience , Mumbai. APICON, Jan 21-25, 2005.

24. Outbreak of Vancomycin Resistant Enterococcal infection in a tertiary centre at the Mumbai Hematology Group monthly meeting in TMH - Jan 2005.

25. Prasad N, Nair R, Deshmukh C, Biswas G, Goyal L, Gupta S, Pai SK, Banavali S, Parikh P. Primary Non Hodgkins Lymphoma of Bone- Tata Memorial Hospital experience, Mumbai. APICON, Jan 21-25, 2005.

26. Shanthi.N, Parikh PM, Prasad N. Assessment of the level of Anxiety and depression in newly diagnosed cancer patients. Mumbai Hematology Group Annual meeting March 2004.

POSTERS PRESENTED

1. Boben T, Pavithran K, Manoj U, Prasad N, Kishore K, Abdul M, Shalini TP, Ganesan TS. Low dose Thalidomide & Dexamethasone in previously untreated Multiple Myeloma. APICON Jan 2008; Cochin.

2. Boben T, Pavithran K, Manoj U, Prasad N, Kishore K, Abdul M, Shalini TP, Ganesan TS. Acute Myeloid Leukaemia: Treatment Experiene at AIMS, Kochi, Kerala. Leukaemias: Molecular Insights to Treatment Paradigms; 7-9, March 2008 Mumbai.

3. Prasad N, PM Parikh, Harimenon, Kumar Prabhash. Treatment of advanced stage NSCLC in elderly with low dose prolonged infusion gemcitabine and standard dose carboplatin doublet. EBM conference Tata Memorial Centre, February 2007.

4. Bakshi A, Goyal L, Hingmire S, Mandhaniya S Prasad N, Bajpai J, Bhagwat R, Mishra BK, Sastry PSRK, Parikh PM. Role of Itraconazole for prophylaxis of fungal infections in BMT setting [1032P]. 31st ESMO Congress, Istanbul, Turkey, September 29-October 3, 2006.

5. Arora B, Vora T, Padhye B, Mishra BK, Goyal L, Prasad N, Banavali S, Bhagwat R, Kurkure P, Nair CN, Pai SK, Ganesh B, Parikh PM Pattern of malignancies in adolescents and young adults in a developing country: Implications for outcome optimization and Health services management. Submitted for SIOP meeting 2006.

6. Arora B, Vora T, Padhye B, Mishra BK, Goyal L, Prasad N, Kurkure P, Sarin R, Jalali R, Gupta T, majumdar D, Parikh PM Long-term survival and late effects in primary intracranial germ cell tumors IN INDIA. Submitted for SIOP meeting 2006.

7. Arora B, Vora T, Padhye B, Mishra BK, Goyal L, Prasad N, Banavali S, Bhagwat R, Kurkure P, Nair CN, Pay SK, Tongaonkar H, Maheshwari A, Yuvraj TB, Qureshi S, Laskar S3, Muckaden M3 Parikh PM Excellent long-term survival but significant late morbidity in childhood germ cell tumors (CGCT): Perspectives from a developing country. Submitted for SIOP meeting 2006.

8. B. Arora, Munira Chaphekar, Purna Kurkure, Shripad Banawali, Roshini Bhagwat, Hari Menon, Prasad N, Geeta Sadani, PS Kadam, Chanda Baisane, Chetan Deshmukh, PSRK Sastry, PM, Parikh Efficacy and toxicity profile of Imatinib Mesylate in chidren and young adults with CML: A single centre experience. 37th Annual Conference of the international Society of Pediatric Oncology SIOP 2005, Vancouver, Canada. Abstract No: P.J.009.

9. Prasad N, Sadani G, Amre Kadam P, C Deshmukh, AVBakshi, G Biswas, A Vora, H Menon, Sastry PSRK, Parikh PM – Isolated CNS Relapse with complete cytogenetic and hematological response in blood and bonemarrow in a case of CML BC: A case report. MHG 2005.

10. Prasad N, C Deshmukh, Kurkure P, Arora B, Banavali SD, Bhagwat R, H Menon, Sadani G, Amre Kadam P, Baisane C, Sastry PSRK, Parikh PM: Use of Imatinib in children and young adults with CML – TMH experience. MHG 2005.

11. VN Karanth, Prasad N, A V Bakshi, K Prabhash, H Menon, G Biswas, Pai VR, Vora A, Parikh PM: Plasmacytoma of external auditory canal – case report. MHG 2005.

12. A Vora, P.M.Parikh, N.Shanthi, V.R.Pai, N.Prasad, S.Goswami, S.Shah. Role Of Hospital Anxiety and Depression scale in reducing need of a formal psychiatric referral in cancer patients. ASCO 2005.

13. PSRK Sastry, R.Bhagwat, G.Biswas, PadmajKulkarni, Alka Khadwal, N Prasad, Ashish Bakshi, PMParikh. Amifostine in autologous stem cell transplantation: comparative data with controls. ESMO 2005.

14. G Biswas, N Prasad, R Bhagwat, P Kulkarni, A Vora, Sarita Shah, PSRK Sastry, PM Parikh. Perceptions about complementary and alternative (CAM) medicine in a tertiary oncology centre in India. ESMO Budapest 2005.

15. A Khadwal, N Prasad, G Biswas, R Bhagwat, A Bakshi, PSRK Sastry, P M Parikh ABO incompatibility in Allogeneic SCT. Proceedings of 10th conference of APBMT.Oct 13-16, 2005 China.

16. Prasad N, Deshmukh C, A V Bakshi, Saikia T, Gupta S, Pai VR, Banavali SD, Kurkure PA, Parikh PM, Dermatologic changes in 200 CML patients treated with Imatinib Mesylate -TMH experience. Annual Conference of Mumbai Hematology Group March 2004.

17. Prasad N, Deshmukh C, A.V. Bakshi, A Vora, V.R.Pai, Parikh PM, Dermatological changes due to Imatinib -TMH experience-International Conference Of Human Genome Update. Hyderabad -August 2004.

18. Khurana R, Biswas G, P kulkarni, Prasad N, Saikia T Nair R, Parikh P. Solitary Intracranial extraosseous Plasmacytoma with multiple myeloma: A case report MHG, 2004.

Publications

1. B. Thomas, K. Pavithran, N Prasad, M. Unni, K. Kumar, A. Majeed, T. S. Ganesan. A phase II study of low dose thalidomide and dexamethasone in previously untreated multiple myeloma. J Clin Oncol 26: 2008 (May 20 suppl; abstr 19520).

2. S Hingmire, Prasad N, Alka Khadwal, D Maru, G Biswas, PSRK Sastry, PM Parikh..Isolated Cutaneous Relapse Of Acute Myeloid Leukemia.JAPI Vol 55. February 2007.

3. Prasad. N, Prabash K, Parikh PM. Hepatocellular Carcinoma presenting as double head. Accepted for publication in Indian Journal of Gastroenterology. Clarified on June 26, 2006.

4. A Bakshi, G Biswas, C Deshmukh, N Prasad, R Nair, PM Parikh. Successful complete regression of isolated intramedullary spinal cord metastases from epithelial ovarian carcinoma with chemotherapy and radiotherapy. Indian Journal of Cancer July 2006 issue.

5. SD Banavali, Lovenish Goyal, Roshni Bhagwat, Prasad N, Sushil Mandhaniya, Brijesh Arora, Amish Vora, Suresh Pai, Sumeet Gujral, PA Kurkure, Melissa Adde, Ian Magrath, Purvish M Parikh. Vinblastine Based Short Pulse B Non Hodgkins Lymphoma Type Chemotherapy with Maintenance Therapy is highly efficacious Treatment for Anaplastic Large Cell Lymphoma (ALCL). ASH 2006.

6. Prabhash K, Biswas G, Prasad N, Karant N, Sastry PS, Parikh PM. Imatinib-induced nail hyper pigmentation in chronic myeloid leukemia. Indian J Dermatol Venereol Leprol. 2006 Jan-Feb; 72(1): 63-4.

7. Khadwal A, Prasad N, Biswas G, Bhagwat R, Sastry PS, Parikh PM. Spontaneous migration of central venous catheter tip. J Assoc Physicians India. 2006 Jan; 54:35.

8. Biswas G, Prasad N, Bhagwat R, Khadwal A, Bakshi AV, Parikh PM. Thalidomide in primary peritoneal mesothelioma. Thalidomide in primary peritoneal mesothelioma. J Surg Oncol. 2006 Apr 1; 93(5): 434.

9. Prabhash K, Prasad N, Biswas G, Parikh PM. Cutaneous metastasis from urologic tumors. Indian J Dermatol Venereol Leprol. 2006 Jan-Feb.

10. Biswas G, Bhagwat R, Khurana R, Menon H, Prasad N, Parikh PM. Brain Metastasis- Evidence based management. A Review article. J Cancer Res Ther, March 2006 - Volume 2.

11. G Biswas, S Hingmire, IN Bagwan, N Prasad, A Bakshi, RF Chinoy, CN Nair. Primitive neuroectodermal tumor (PNET) of thyroid – A case report. Oral Oncology Extra, May 2006.

12. Prasad N, Biswas G, Khadwal A, Prabash K, Parikh PM. Carcinoma Esophagus with Brain Metastasis. A letter to Editor. Indian Journal of Medical and Pediatric Oncology, June 2006- Vol 27, No.2.

13. Prasad.N, Sastry PSRK, B.K.Mishra, Sushil M, Roshni Bhagwat, Ashish Bakshi, G Biswas, P.M.ParikhOutcome of Allogenic Stem Cell Transplant in CML analyzed according to the EBMT Score based risk groups – A Single Institution Experience. Biology of Blood and Marrow Transplantation.

14. Biswas G, Bhagwat R, Khurana R, Prasad N, Sastry PSRK, Parikh PM. Multiple Myeloma presenting as a Suprasellar Plasmacytoma: A Pictorial CME. JAPI 2005; 53: 24.

15. Prasad N, C D Deshmukh, G Biswas, A Bakshi, PSRK Sastry, P M Parikh. Dermatological Toxicity of Imatinib Mesylate: A Pictorial CME. JAPI 2005; Apr;53:298.

16. Prasad N, Chaya Dhoke, Breast Cancer - chemotherapy and nursing management. Oncology Nursing News Letter Jan to March 2005. Vol 7. Issue1.

17. PM Parikh, Prasad N, R.C.Mistry, J.P.Agarwal, V.R.Pai, R.Nair, S.Gupta, P.S.Sastry, A Vora, K.A.Dinshaw: Treatment of advanced NSCLC with low dose gemcitabine and carboplatin.-ASCO abstract book 2005.

18. K.Prabash, P.S.R.K Sastry, G Biswas, A Bakshi, Prasad N, H Menon & PM Parikh. Pregnancy outcome of two patients treated with imatinib. Letter to editor. Ann Oncol. 2005 Aug 12.

19. Sastry P, Bhagwat R, Biswas G, Khadwal A, Prasad N, Bakshi A, Parikh P. Trial of amifostine in autologous stem cell transplant. Bone Marrow Transplant.2005 Nov 7.

20. Purvish Parikh, C.D.Deshmukh, A.V.Bakshi, Prasad N, A Vora, V.R.Pai, P.A. Kurkure, R. Nair, S.K. Pai Dermatological side effects of Imatinib Mesylate correlate with cytogenetic response in CML patients from India. Annals of Oncology, Volt 15, Supplement 3, 2004.

LANGUAGES KNOWN

English, Hindi, Tamil and Malayalam

REFEREES

1. Prof. Dr. PM.Parikh,

Medical Oncologist and Hematologist

Previously HOD, Dept. of Medical Oncology

Tata Memorial Hospital, Mumbai, Parel, 400012

purvish1@

2. Prof. Dr. Pavithran

Medical Oncologist and Hematologist

Head Dept. Medical Oncology

Amrita Institute Of Medical Sciences

Kochi

Kerala, India

pavithrank@aims.amrita.edu

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download